Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mills

Showing results (441-450 of 467) with videos related to

Pageof 47
Sort By:
Leukemia|March 30, 2011
Gene expression profiling in MDS and AML: potential and future avenuesK Theilgaard-Mönch, J Boultwood, S Ferrari, et al.
Human Vaccines & Immunotherapeutics|August 8, 2020
Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodiesJacob T Beaver, Lisa K Mills, Dominika Swieboda, et al.
Transplantation|March 22, 2002
Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplantsSusan L Orloff, Daniel N Streblow, Cecilia Soderberg-Naucler, et al.
Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.
Translational Psychiatry|November 16, 2016
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathologyR W Paterson, W E Heywood, A J Heslegrave, et al.
The Journal of Physical Chemistry Letters|October 24, 2025
Exciton Quenching at Grain Boundaries in C<sub>60</sub> Thin FilmsRysa Greenwood, Bradley G Guislain, MengXing Na, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2020
Incorporating patient generated health data into pharmacoepidemiological researchAlison Bourke, William G Dixon, Andrew Roddam, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2000
The discovery and synthesis of highly potent, A2a receptor agonistsS E Keeling, F D Albinson, B E Ayres, et al.
Blood|May 25, 2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyDavid M Ross, Susan Branford, John F Seymour, et al.
Skeletal Radiology|June 12, 2026
Standardized MRI nomenclature for knee meniscal lesions: SSR consensus panel reportJie C Nguyen, Tetyana Gorbachova, Dyan V Flores, et al.
Pageof 47

Showing results (441-450 of 467) with videos related to

Sort By:
Pageof 47
Leukemia|March 30, 2011
Gene expression profiling in MDS and AML: potential and future avenuesK Theilgaard-Mönch, J Boultwood, S Ferrari, et al.
Human Vaccines & Immunotherapeutics|August 8, 2020
Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodiesJacob T Beaver, Lisa K Mills, Dominika Swieboda, et al.
Transplantation|March 22, 2002
Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplantsSusan L Orloff, Daniel N Streblow, Cecilia Soderberg-Naucler, et al.
Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.
Translational Psychiatry|November 16, 2016
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathologyR W Paterson, W E Heywood, A J Heslegrave, et al.
The Journal of Physical Chemistry Letters|October 24, 2025
Exciton Quenching at Grain Boundaries in C<sub>60</sub> Thin FilmsRysa Greenwood, Bradley G Guislain, MengXing Na, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2020
Incorporating patient generated health data into pharmacoepidemiological researchAlison Bourke, William G Dixon, Andrew Roddam, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2000
The discovery and synthesis of highly potent, A2a receptor agonistsS E Keeling, F D Albinson, B E Ayres, et al.
Blood|May 25, 2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyDavid M Ross, Susan Branford, John F Seymour, et al.
Skeletal Radiology|June 12, 2026
Standardized MRI nomenclature for knee meniscal lesions: SSR consensus panel reportJie C Nguyen, Tetyana Gorbachova, Dyan V Flores, et al.
Pageof 47